BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38685734)

  • 1. No-Touch Radiofrequency Ablation Using Twin Cooled Wet Electrodes for Recurrent Hepatocellular Carcinoma Following Locoregional Treatments.
    Hong SJ; Kim JH; Yoon JH; Park JH; Yoon JH; Kim YJ; Yu SJ; Cho EJ; Lee JM
    Korean J Radiol; 2024 May; 25(5):438-448. PubMed ID: 38685734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No-Touch vs. Conventional Radiofrequency Ablation Using Twin Internally Cooled Wet Electrodes for Small Hepatocellular Carcinomas: A Randomized Prospective Comparative Study.
    Suh YS; Choi JW; Yoon JH; Lee DH; Kim YJ; Lee JH; Yu SJ; Cho EJ; Yoon JH; Lee JM
    Korean J Radiol; 2021 Dec; 22(12):1974-1984. PubMed ID: 34668352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Outcomes of Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: Effects of the Electrode Type and Placement Method.
    Park J; Lee MW; Ahn SH; Han S; Min JH; Cha DI; Song KD; Kang TW; Rhim H
    Korean J Radiol; 2023 Aug; 24(8):761-771. PubMed ID: 37500577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
    Lee DH; Lee MW; Kim PN; Lee YJ; Park HS; Lee JM
    Radiology; 2021 Oct; 301(1):229-236. PubMed ID: 34313474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation using internally cooled wet electrodes in bipolar mode for the treatment of recurrent hepatocellular carcinoma after locoregional treatment: A randomized prospective comparative study.
    Choi JW; Lee JM; Lee DH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Cho EJ
    PLoS One; 2020; 15(9):e0239733. PubMed ID: 32986758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
    Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
    Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
    Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
    Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
    Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
    Min JH; Lee MW; Rhim H; Han S; Song KD; Kang TW; Jeong WK; Cha DI; Kim JM; Choi GS; Kim K
    Eur Radiol; 2024 Jan; 34(1):525-537. PubMed ID: 37526668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can "no-touch" radiofrequency ablation for hepatocellular carcinoma improve local tumor control? Systematic review and meta-analysis.
    Kim TH; Lee JM; Lee DH; Joo I; Park SJ; Yoon JH
    Eur Radiol; 2023 Jan; 33(1):545-554. PubMed ID: 35907024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of hepatocellular carcinoma.
    Kim JH; Kim PN; Won HJ; Shin YM
    AJR Am J Roentgenol; 2012 Feb; 198(2):471-6. PubMed ID: 22268196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of no-touch radiofrequency ablation in the treatment of single small hepatocellular carcinoma: A single center long-term follow-up study.
    Wu G; Li J; Li C; Ou X; Feng K; Xia F; Chen Z; Zhang L; Ma K
    Cancer Med; 2023 Mar; 12(6):6571-6582. PubMed ID: 36444873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency ablation with multiple electrodes for medium-sized hepatocellular carcinomas.
    Lee J; Lee JM; Yoon JH; Lee JY; Kim SH; Lee JE; Han JK; Choi BI
    Korean J Radiol; 2012; 13(1):34-43. PubMed ID: 22247634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
    Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
    Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
    Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion imaging-guided radiofrequency ablation with artificial ascites or pleural effusion in patients with hepatocellular carcinomas: the feasibility rate and mid-term outcome.
    Kim JH; Lee JY; Yu SJ; Lee DH; Joo I; Yoon JH; Kim YJ; Yoon JH; Lee JM
    Int J Hyperthermia; 2023; 40(1):2213424. PubMed ID: 37253458
    [No Abstract]   [Full Text] [Related]  

  • 17. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
    J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
    Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
    J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
    Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
    Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation combined with chemoembolization for intermediate-sized (3-5 cm) hepatocellular carcinomas under dual guidance of biplane fluoroscopy and ultrasonography.
    Min JH; Lee MW; Cha DI; Jeon YH; Shin SW; Cho SK; Rhim H; Lim HK
    Korean J Radiol; 2013; 14(2):248-58. PubMed ID: 23483753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.